Max Remedies Throat Lozenges
SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE MEDICINAL PRODUCT
Max Remedies Throat Lozenges
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
Cetylpyridinium Chloride BP 1.4mg
3 PHARMACEUTICAL FORM
Compressed Lozenge
4 CLINICAL PARTICULARS
4.1 Therapeutic indications
For the symptomatic relief of non-inflammatory sore throat and the congestion caused by colds and nasal catarrh.
4.2 Posology and method of administration
Adults, elderly and children over 12 years: Suck one lozenge every four hours as required.
Oral administration.
4.3 Contraindications
None known.
4.4 Special warnings and precautions for use
Keep out of reach of children. If symptoms persist consult your doctor.
4.5 Interaction with other medicinal products and other forms of interaction
None reported.
4.6 Pregnancy and lactation
No animal or human data to prove it is unsafe.
4.7 Effects on ability to drive and use machines
None.
4.8 Undesirable effects
Skin rash
4.9 Overdose
Symptoms: Nausea, vomiting, gastric irritation and collapse.
Emergency procedures: gastric lavage and appropriate symptomatic supportive measures.
5 PHARMACOLOGICAL PROPERTIES
5.1 Pharmacodynamic properties
Cetylpyridinium Chloride is a cationic disinfectant with bactericidal properties.
5.2 Pharmacokinetic properties
Not applicable.
5.3 Preclinical safety data
None.
6 PHARMACEUTICAL PARTICULARS
6.1 List of excipients
Menthol
Methyl Salicylate Citric Acid Eucalyptus Oil Sucrose Sorbitol
Magnesium Stearate
6.2 Incompatibilities
None Known.
6.3 Shelf life
3 years
6.4 Special precautions for storage
None.
6.5 Nature and contents of container
Packs of 20 and 35 tablets in white polypropylene tubes with HD polythene caps.
6.6 Special precautions for disposal
No special requirements.
7 MARKETING AUTHORISATION HOLDER
Max Remedies Limited Stoney Gate House 2 Greenfield Road Holmfirth West Yorkshire HD9 2JT
8 MARKETING AUTHORISATION NUMBER(S)
PL 31308/0026
9 DATE OF FIRST AUTHORISATION/RENEWAL OF THE
AUTHORISATION 26 February 1990
10 DATE OF REVISION OF THE TEXT
20th July 2009